Last10K.com

America Great Health (AAGH) SEC Filing 8-K Material Event for the period ending Tuesday, June 26, 2018

America Great Health

CIK: 1098009 Ticker: AAGH


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  June 26, 2018
 
America Great Health
(Exact name of registrant as specified in charter)

WYOMING
(State or other jurisdiction of incorporation)
 
0-27873
 
98-0178621
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
 
1609 W Valley Blvd., #338,
Alhambra, CA 91803
 
28277
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code:  (626) 576-1299
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 


 
Section 4.  Matters Related to Accountants and Financial Statements

Item 4.01.  Changes in Registrant’s Certifying Accountant
 
On June 26, 2018, America Great Health (the “Company”) was notified of the resignation of its independent registered public accounting firm, Sadler, Gibb & Associates, LLC, effective that date. The Company’s Board of Directors accepted the resignation of Sadler, Gibb & Associates, LLC upon receipt of the notification and has commenced a search for a new independent public accounting firm.

No report of Sadler, Gibb & Associates, LLC on the financial statements of the Company for the quarter ended December 31, 2017, and March 31, 2018 contained an adverse opinion or a disclaimer of opinion or was qualified or modified as to uncertainty, audit scope, or accounting principles. Sadler, Gibb & Associates, LLC, at the time of resignation, had not yet released a report or opinion regarding the Company’s financial statements for the fiscal year ended June 30, 2018. During the time of their engagement and up through their resignation on June 26, 2018, there were no disagreements with Sadler, Gibb & Associates, LLC on any matters of accounting principles or practices, financial statement disclosure or auditing scope and procedures which, if not resolved to the satisfaction of Sadler, Gibb & Associates, LLC, would have caused Sadler, Gibb & Associates, LLC to make reference to the matter in their report. There were no reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K) during the time of their engagement and up through their resignation on June 26, 2018..

The Company has provided a copy of the foregoing disclosures to Sadler, Gibb & Associates, LLC and requested that Sadler, Gibb & Associates, LLC furnish it with a letter addressed to the Securities and Exchange Commission stating whether Sadler, Gibb & Associates, LLC agrees with the above statements. A copy of Sadler, Gibb & Associates, LLC’s letter to the Securities and Exchange Commission, dated July 2, 2018, is filed as Exhibit 16.1 to this Form 8-K.

Section 9.  Financial Statements and Exhibits

Item 9.01.  Financial Statements and Exhibits

     
(d)   Exhibits
 
 
 
 
 
Exhibit
Number
    
Exhibit Title or Description
 
16.1
 


 




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
             
AMERICA GREAT HEALTH
   
                
   
 
                        
                
   
 
Dated: July 2, 2018
                
By: 
/s/ Mike Q. Wang  
 
 
 
President
 
 
 
 


View differences made from one to another to evaluate America Great Health's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by America Great Health.

Continue

Assess how America Great Health's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

America Great Health's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

America Great Health provided additional information to their SEC Filing as exhibits

Ticker: AAGH
CIK: 1098009
Form Type: 8-K Corporate News
Accession Number: 0001185185-18-001204
Submitted to the SEC: Mon Jul 02 2018 3:35:32 PM EST
Accepted by the SEC: Mon Jul 02 2018
Period: Tuesday, June 26, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Accountant Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/aagh/0001185185-18-001204.htm